CCR2 improves tumor directed CAR-T cell trafficking in ovarian cancer.
Saved in:
| Title: | CCR2 improves tumor directed CAR-T cell trafficking in ovarian cancer. |
|---|---|
| Authors: | Kumar R; Massachusetts General Hospital Cancer Center, Boston, MA, United States., Veillard IE; Massachusetts General Hospital Cancer Center, Boston, MA, United States., Xu M; Massachusetts General Hospital Cancer Center, Boston, MA, United States., Al-Alem L; Meigs Division of Gynecologic Oncology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, United States., Rueda BR; Meigs Division of Gynecologic Oncology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States., Yeku OO; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 Dec 05; Vol. 16, pp. 1651526. Date of Electronic Publication: 2025 Dec 05 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
